
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Valion Bio (NASDAQ:VBIO) through any online brokerage.
Other companies in Valion Bio’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Valion Bio to provide a consensus price target.
The stock price for Valion Bio (NASDAQ: VBIO) is $1.1165 last updated October 19, 2026 at 5:19 AM EDT.
There are no upcoming dividends for Valion Bio.
Valion Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Valion Bio.
Valion Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.